CSIR Central

Development of stevioside Pluronic-F-68 copolymer based PLA-nanoparticles as an antidiabetic nanomedicine

IR@IHBT: CSIR-Institute of Himalayan Bioresource Technology, Palampur

View Archive Info
 
 
Field Value
 
Title Development of stevioside Pluronic-F-68 copolymer based PLA-nanoparticles as an antidiabetic nanomedicine
 
Creator Barwala,, Indu
Sood, Anil
Sharma, Mohit
Singh , Bikram
Yadav, Subhash C.
 
Subject Plant sciences
Plant Biotechnology
 
Description Stevioside (FDA approved nontoxic natural non-caloric sweetener) has been reported to have very good antidiabetic potential but its use as therapeutic drug is restricted in human due to its deprived intestinal absorption and poor bioavailability. We have nano-bioconjugated this molecule on biodegradable Pluronic-F-68 copolymer based PLA nanoparticles by nanoprecipitation method (spherical, size range 110–130 nm) to overcome deprived intestinal absorption and to enhance the bioavailability. The drug loading calculated by the standard calibrated HPLC was 16.32 ± 4% (w/w). The in vitro release study showed the initial burst followed by the sustained release. The half release and complete release were observed on 25 ± 4 h and 200 ± 10 h respectively. This newly formulated nanostevioside showed very high potential to be used as antidiabetic nanomedicine for safe and effective use in vivo.
 
Date 2013
 
Type Article
PeerReviewed
 
Format application/pdf
 
Identifier http://ihbt.csircentral.net/1319/1/100_Deveopment_of_stevioside.pdf
Barwala,, Indu and Sood, Anil and Sharma, Mohit and Singh , Bikram and Yadav, Subhash C. (2013) Development of stevioside Pluronic-F-68 copolymer based PLA-nanoparticles as an antidiabetic nanomedicine. Journal of Colloids and Surfaces B: Biointerfaces, 101. pp. 510-516.
 
Relation http://ihbt.csircentral.net/1319/